Full Text
PCV9 ASSESSING RISK REDUCTION AND NNT AMONG TYPE 2 DIABETICS TREATED WITH FIBRIC ACID DERIVATIVES

Abstract

Authors

AJ Boening AL Phillips M Cifaldi T Ashraf

Back to Volume 5, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×